Dr. PETER SCHOTTE

Active

Private limited companyfounded 2014active for 12 yearsKleine Heidelaan 1, 2820 Bonheiden, BelgiumKBO/BCE: BE 0550.873.391

From the official registers: KBO 12 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. PETER SCHOTTE has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €326,982 and a net result of €80,122. Equity is growing by about 9.7% per year across the filed financial years. Its solvency ranks better than 76% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

Dr. PETER SCHOTTEActiveChecked score 96/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 24-04-2014 Normal situation
Legal form: Private limited company
Registered office: Kleine Heidelaan 1, 2820 Bonheiden
Activity: General medical practice NACE 86210
Establishment unit: 2.230.424.235 2800 Mechelen, since 24-04-2014
Financial year end: 31 December
Peppol: Reachable

Company details

Who decides

Board

Schotte PeterDirector · since 23-04-2014

Board & ownership

How it is doing

96 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts 2025

Gross margin: €124,089; ▲ 2.4%
Turnover: ≈ €230,000; estimated
Profit: €80,122; ▲ 5.8%
Equity: €326,982; ▲ 11.6%
Total assets: €387,099; ▲ 15.8%

2025 accounts on time

Filed on 31-07-2026at the National Bank

Financials

Why 96lowers riskLiquidity: current ratio 6.17, cash €371,087Sector: Human health activities (NACE 86)Equity €326,982 (84.5% of total assets)Size: total assets €387,099Show the evidence

Checked score

Score 2025

96 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 69% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 84.5% of total assets

Liquidity 97-2

short-term debt 15.5% · cash 95.9%

Profitability 95-2

return on assets 20.7%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value

Credit of up to €30,000 on 30-day terms is acceptable

Liquidity ample (current ratio 6.17, compared with 7.49 in 2024, above the usual 1.5; short-term debt: 15.5% and cash: 95.9% of total assets), and 15.5% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 85% on liquidity, 53% on profitability and 54% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Liquidity: current ratio 6.17, cash €371,087

NBB · annual accounts

Sector: Human health activities (NACE 86)

KBO

Equity €326,982 (84.5% of total assets)

NBB · annual accounts

Size: total assets €387,099

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

on the day

2024

4 days late

2023

1 day late

2022

31 days late

2021

5 days early

2020

31 days early

2019

27 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 4 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 2 August (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: 8 profitable years in a rowprofit 2025: €80,122 8 years View

Documents

Key facts about Dr. PETER SCHOTTE

What is the company number of Dr. PETER SCHOTTE?: 0550.873.391. In Belgium the VAT number is the company number with BE in front: BE 0550.873.391.
Where is Dr. PETER SCHOTTE based?: The registered office is at Kleine Heidelaan 1, 2820 Bonheiden.Company details
What does Dr. PETER SCHOTTE do?: According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. PETER SCHOTTE?: Private limited company (BV).
When was Dr. PETER SCHOTTE founded?: On 24-04-2014.
Is Dr. PETER SCHOTTE still active?: Yes, Dr. PETER SCHOTTE is an active enterprise in the KBO register.
What is the turnover of Dr. PETER SCHOTTE?: ≈ €230,000 in financial year 2025. Estimated from the gross margin of €124,089: probably between €180,000 and €280,000, based on 30 comparable companies, NACE 86210.Financials
Is Dr. PETER SCHOTTE profitable?: In financial year 2025, Dr. PETER SCHOTTE made a profit of €80,122.
Where can I find the annual accounts of Dr. PETER SCHOTTE?: Dr. PETER SCHOTTE filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. PETER SCHOTTE due?: By 31-07-2027, for financial year 2026.Timeline